Urine-Based Biomarker Test Uromonitor® in the Detection and Disease Monitoring of Non-Muscle-Invasive Bladder Cancer—A Systematic Review and Meta-Analysis of Diagnostic Test Performance
Anton Kravchuk(Barmherzige Brüder Klinikum St. Elisabeth in Straubing), Matthias May(Barmherzige Brüder Klinikum St. Elisabeth in Straubing), Sabine Brookman‐May(Ludwig-Maximilians-Universität München), Ralph M. Wirtz(Siemens Healthcare (Germany)), Paula Soares(i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto), Ingmar Wolff(Universitätsmedizin Greifswald), Lisa Kollitsch(Donauspital), Kay-Patrick Braun(Otto-von-Guericke-Universität Magdeburg), Maximilian Burger(University of Regensburg), Katharina Hauner(TUM Klinikum), Johannes Bründl(University of Regensburg), Martin Burchardt(Universitätsmedizin Greifswald), Christian Gilfrich(Barmherzige Brüder Klinikum St. Elisabeth in Straubing)
Cited by 18
Related Papers
The mTOR Signalling Pathway in Human Cancer
|International Journal of Molecular Sciences|2012|831
The Effect of Exercise Training Programs on Bone Mass: A Meta-analysis of Published Controlled Trials in Pre- and Postmenopausal Women
|Osteoporosis International|1999|594
Prediction of 90-day Mortality After Radical Cystectomy for Bladder Cancer in a Prospective European Multicenter Cohort
|European Urology|2014|206